Original Content

image
Could CAVADEX Be A “Cure” for Heart Disease?
Cyclodextrins, such as the one used in products like Cavadex (https://cavadex.com/), have gained attention for their potential effects in various medical applications, including their impact on heart disease and arterial plaque. While research in this area is still ongoing, here’s an explanation of how cyclodextrin might help in reducing arterial plaque and potentially aid in treating heart disease. Read More.

BY Keith Ablow, MD

01.20.25

image
HELP22 VETERANS CHARITY ADOPTS A PLATOON
HELP22 is a nonprofit organization with a powerful mission: to restore the value of life for veterans and military service members through coaching, counseling, and mentoring. The organization’s ultimate goal is to prevent suicide, a devastating reality among veterans whose suicide rate is 57% higher than the national average. HELP22 directly challenges veterans with a rallying cry: "Re-enlist in life, one day at a time." Read More.

BY Tiffany Bartholomew, https://www.help22.org/

01.19.25

image
Behind the Badge and Uniform: The Hidden Mental Health Crisis of America's Protectors
n the corners of police stations, fire stations and military bases across the United States, a silent struggle is unfolding. Beyond the heroic narratives and stoic public personas, veterans and law enforcement officers are confronting a profound mental health crisis that threatens not just individual well-being but the very fabric of public safety. Read More.

BY Kathryn Munoz, PhD, MPH Special to Louder.News (Second in a series of articles addressing the mental health crisis in America)

01.14.25

image
Dr. Keith Ablow: TWENTY-FIVE WAYS TO IMPROVE YOUR LIFE IN 2025
Beginning in 2015, I began publishing a list of ways to improve your life. Last year I published, “Twenty-Two Ways to Improve Your Life in 2022.” The year before that I published “Twenty-One Ways to Improve Your Life in 2021.” You get the idea. The tradition continues this year, with the addition of No. 25. Read More.

BY Keith Ablow, MD

12.30.24

image
The Mental Health Crisis in America: A Nation in Distress ... The First in a Series of Articles
As the United States grapples with the ongoing COVID-19 pandemic, a more insidious crisis has been unfolding beneath the surface: a mental health epidemic that threatens to upend the very fabric of our society. According to a recent report, approximately 1 in 5 American adults experience a mental health condition each year, with a staggering 50 million individuals affected. The pandemic has only exacerbated this crisis, with rates of anxiety and depression soaring among marginalized communities. Read More.

BY By Kathryn Munoz PhD., MPH, Special to Louder.News

12.11.24

image
From Patent Medicines to Digital Campaigns: The Transformative Journey of Pharmaceutical Advertising
In the United States, pharmaceutical advertising has undergone a profound transformation, evolving from the dubious claims of patent medicines in the 18th and 19th centuries to the contemporary landscape dominated by digital marketing and direct-to-consumer advertising (DTCA). As spending on pharmaceutical advertising soared to approximately $6.88 billion in 2021, the industry grapples with the complexities of marketing its products and with ethical considerations and regulatory frameworks aimed at protecting consumers. Read More.

BY Kathryn Munoz, PhD, MPH Special to Louder.News . . . PHARMA INK: A LOOK BEHIND THE MEDICINES YOU TAKE

12.03.24

image
The COVID-19 Pandemic and the Pharma Industry: A Complex Web of Truth and Deception
The COVID-19 pandemic brought the world to a standstill. Since then, the pharmaceutical industry has been at the forefront of the global response. With the development and distribution of vaccines, treatments, and diagnostic tools, the pharma and device industries played a crucial role in developing treatments and vaccines. However, a new book, "The Pfizer Papers," written by Amy Kelly and investigative journalist Naomi Wolf, has shed light on the complex and often controversial relationship between the pharma industry and the public. Read More.

BY Kathryn Munoz, PhD, MPH Special to Louder.News . . . PHARMA INK: A LOOK BEHIND THE MEDICINES YOU TAKE

11.26.24

image
GOP Must Pre-Empt Sell-Out to Chinese Environmental Hypocrisy and Disastrous Foreign Policy
No matter how much he dominates every rally, interview, and debate, this election is not guaranteed for President Trump. The Democratic machine is running at full capacity, doing everything in its power to ensure a progressive victory, from George Soros buying radio stations to fast-tracking citizenship approvals. If Tim Walz is their best offering, we should be alarmed by the incompetence a Democratic victory could bring. Republicans must have a plan to win—and, if the unthinkable should happen, to "Kamala-proof" the levers of power. The Chinese Communist Party remains the biggest threat to America in 2025. The contrast between the candidates on this issue is stark. Senator JD Vance emphasizes taking back our economic dominance by re-shoring businesses and calling out China as a bad actor on both human rights and the environment. Meanwhile, Walz couldn't even remember why he lied about being in China during the Tiananmen Square Massacre. The possibility of this level of incompetence in the White House should concern every American. Read More.

BY Saul Anuzis, President of the 60 Plus Association

11.05.24

image
Pharmaceuticals and the Environment: Mitigating a Growing Concern
Recently, the intersection of pharmaceuticals and environmental health has become an urgent and pressing concern, garnering significant attention from scientists, policymakers, and the public alike. Pharmaceuticals, while providing immense benefits to people and animals, pose a potential risk to the environment, particularly as many drugs are broken down by humans and then released into water bodies and soil. These compounds can affect aquatic life and potentially enter the human food chain, raising serious concerns over long-term ecological and health impacts. Read More.

BY Kathryn Munoz, PhD, MPH

11.04.24

image
AN OPEN LETTER TO THE FDA: Founder of Cavadex Takes on FDA, Asserts He Has Cure for Atherosclerosis
Kyle Hodgetts, Founder of Cholrem Pty Ltd and Inventor of Cavadex Takes on the FDA and asserts they are suppressing the cure for blockages in arteries. Read More.

BY Kyle Hodgetts, Founder of Cholrem Pty Ltd, Inventor of Cavadex

10.18.24

image
Kyle Hodgetts, Founder of Cholrem Pty Ltd and Inventor of Cavadex, Says He Has Cure for Atherosclerosis
I’ve had enough of the current state of the medical industry. It is the most corrupt system I have encountered, with the FDA and the US government continually supporting medications that are not only ineffective but toxic—clearly prioritising pharmaceutical profits over patients’ health. Since July 2020, Cavadex has been used by thousands globally, showing life changing results. Cavadex reverses heart disease by clearing arterial plaque, reducing cholesterol, and improving overall cardiovascular function. It even enhances liver and kidney health by allowing blood to flow freely, even in the smallest blood vessels. Heart disease is the leading cause of death worldwide, and Cavadex is the only treatment that shows rapid, measurable results in reducing arterial plaque. Read More.

BY Kyle Hodgetts, Founder of Cholrem Pty Ltd, Inventor of Cavadex

10.18.24

image
Enhancing Medication Compliance and Improving Patient Engagement with Technology and Artificial Intelligence
Technology and AI are improving how people stick to medication schedules! There are plenty of tools that can prompt individuals to take their meds as prescribed and keep tabs on their adherence levels—some even let them stay in touch with healthcare professionals. Read More.

BY Kathryn Munoz, PhD, MPH

10.17.24

image
MAKER OF CAVADEX ASSERTS IT CAN REVERSE ATHEROSCLEROSIS AND SAVE MILLIONS OF LIVES
Kyle Hodgetts, the Founder of Cholrem Pty Ltd and inventor of Cavadex asserts it can reverse atherosclerosis and dramatically help those with heart disease. The FDA wants more proof, but Hodgetts says the millions of people who die of heart disease every year shouldn't have to wait for years of scientific studies when the ingredient in Cavadex--known as a cyclodextrin--is already FDA approved. Read More.

BY Kyle Hodgetts, Founder of Cholrem.com

10.10.24

image
The Growing Influence of Patient Advocacy Groups in the Pharmaceutical Industry
In recent years, something big has changed how patients, pharmaceutical companies, and government agencies like the Food and Drug Administration (FDA) work together. Patient advocacy groups now play a more significant role in deciding which medicines to develop and how to make them available to the public. Read More.

BY Kathryn Munoz, PhD, MPH

10.09.24

image
Even as a Pharma Insider, I Worry that the Pharma Industry Can Sometimes Bankrupt Patients
While the pharmaceutical industry can function to create life-saving drugs, it’s time the industry underwent significant change. Over my 25 years of experience launching drugs for cancer, rare diseases, and immunologic illnesses, while working for Fortune 100 companies and start-ups, a veteran of the pharma industry has seen amazing progress, but also some troubling issues. Read More.

BY Kathryn Munoz, PhD, MPH

09.06.24

Get latest news delivered daily!

We will send you breaking news right to your inbox

© 2025 louder.news, Privacy Policy